Show simple item record

What is the best treatment approach for sporadic late-onset nemaline myopathy associated with "monoclonal gammopathy of neurological significance"?

dc.contributor.authorGÜNDÜZ, Ayşegül
dc.contributor.authorEŞKAZAN, Ahmet Emre
dc.date.accessioned2021-12-10T09:36:34Z
dc.date.available2021-12-10T09:36:34Z
dc.date.issued2021
dc.identifier.citationEŞKAZAN A. E. , GÜNDÜZ A., "What is the best treatment approach for sporadic late-onset nemaline myopathy associated with "monoclonal gammopathy of neurological significance"?", INTERNATIONAL JOURNAL OF CANCER, cilt.148, sa.11, ss.2638-2639, 2021
dc.identifier.issn0020-7136
dc.identifier.othervv_1032021
dc.identifier.otherav_06b7583f-4944-432b-8b41-c71493ecfa86
dc.identifier.urihttp://hdl.handle.net/20.500.12627/168093
dc.identifier.urihttps://doi.org/10.1002/ijc.33491
dc.language.isoeng
dc.subjectOnkoloji
dc.subjectOncology
dc.subjectHealth Sciences
dc.subjectDahili Tıp Bilimleri
dc.subjectİç Hastalıkları
dc.subjectSağlık Bilimleri
dc.subjectTıp
dc.subjectKlinik Tıp (MED)
dc.subjectKlinik Tıp
dc.subjectONKOLOJİ
dc.titleWhat is the best treatment approach for sporadic late-onset nemaline myopathy associated with "monoclonal gammopathy of neurological significance"?
dc.typeMakale
dc.relation.journalINTERNATIONAL JOURNAL OF CANCER
dc.contributor.departmentİstanbul Üniversitesi-Cerrahpaşa , Cerrahpaşa Tıp Fakültesi , Dahili Tıp Bilimleri Bölümü
dc.identifier.volume148
dc.identifier.issue11
dc.identifier.startpage2638
dc.identifier.endpage2639
dc.contributor.firstauthorID2635858


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record